Medication info
Daplogin 5 mg (Dapagliflozin Propanediol Monohydrate)

Daplogin 5 mg (Dapagliflozin Propanediol Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Aliko Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
Box - 28 tablets/box [7 tablets/Alu-Alu x 4], Bottle - 28 tablets/bottle, Bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 202200929 · Approved 2022.03.04 · Insurance code 656005320

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients receiving dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Aliko Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • poor blood sugar control
  • cardiovascular diseases
  • cardiovascular risk factors
View approved original text

This drug is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be used alone or in combination with other medications to control blood sugar. It is particularly helpful for patients whose blood sugar is poorly controlled and who have cardiovascular diseases or risk factors. This drug is used to improve blood sugar levels and reduce the risk of cardiovascular events.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients receiving dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This drug should not be used in certain patients. For example, it is not to be administered to those with allergies to the components or additives, patients with type 1 diabetes, diabetic ketoacidosis, or patients undergoing dialysis. Caution is required in patients with reduced fluid volume or impaired kidney function. This drug may lower blood pressure and affect kidney function, so fluid status and kidney function must be evaluated before administration, and symptoms of hypotension and changes in kidney function should be monitored after administration. In patients with moderate to severe kidney dysfunction, blood sugar control effects may decrease, and it is not recommended for patients with very low kidney function. Using this drug may lead to adverse reactions such as genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, diabetic ketoacidosis, and rarely, Fournier's gangrene. Especially, genital and urinary tract infections appear more frequently in women and patients with a history of such infections. The risk of hypoglycemia may increase when used with other blood sugar-lowering agents such as insulin or sulfonylureas, and dosage adjustments may be required in such cases. Patients at risk of reduced fluid volume and hypotension, particularly the elderly or those on diuretics, should be more cautious, and should consult healthcare providers immediately if symptoms occur. Pregnant women or nursing mothers are advised not to use this drug, and should discontinue use if pregnancy is confirmed. The safety and efficacy of this drug in children have not been established, so it is not used in pediatric patients. In case of overdose, there is no specific antidote, so treatment should be received according to symptoms under medical supervision. This drug does not significantly affect driving or machine operation, but caution is needed in cases of hypoglycemia. Finally, this drug must be stored out of the reach of children and kept in its original container to maintain quality.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, reduced fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, reduced renal creatinine clearance early in treatment, dyslipidemia, elevated serum creatinine early in treatment, increased blood urea, weight loss, rash, angioedema, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, gastroesophageal reflux disease, upper abdominal pain, diverticulosis, intestinal perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, sensory disturbances, cerebral infarction, nerve compression, sinusitis, pneumonia, pulmonary tuberculosis, lassitude, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, bile duct stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chest pain, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, hesitancy, urinary stones, increased serum lactate, lymphopenia, vitamin D deficiency, increased appetite, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, coma, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, bronchitis, herpes zoster, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, influenza-like syndrome, breast mass, erectile dysfunction, benign prostatic hyperplasia, mastalgia, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, irregular menstruation, hair loss, dermatitis, xerosis, allergic dermatitis, contact dermatitis, diabetic foot ulcer, hyperhidrosis eczema, dyshidrotic eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, dry eye, eye pain, retinal disorders, visual impairment, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, double vision, eyelid swelling, keratitis, ocular hypertension, visual disability, vitreous floaters, oral and pharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, palpitations, anxiety disorder, nocturia, insomnia, fatty liver, gallbladder polyp, tinnitus, anal-genital warts, adenoma, neuroma, pituitary neoplasm of unspecified type, male hypogonadism, thyroid cyst, thyroid mass, food allergy, erythrocytosis, dyspepsia, nausea, diarrhea, vomiting, urinary retention, urine abnormalities, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, hypersalivation, headache, nasopharyngitis, upper respiratory infection, hunger, vaginal discharge, pruritus, arthralgia, palpitations

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to protect it from air and moisture. The storage temperature should ideally be maintained between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

Box - 28 tablets/box [7 tablets/Alu-Alu x 4], Bottle - 28 tablets/bottle, Bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.